Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07414719

Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.

Prospective, Randomized, Cluster-controlled, Multicenter Study to Evaluate the Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,422 (estimated)
Sponsor
Centre Leon Berard · Academic / Other
Sex
All
Age
11 Years – 17 Years
Healthy volunteers
Accepted

Summary

Human papillomaviruses (HPV) are very common contagious viruses: approximately 70% of men and women will be infected during their lifetime. Vaccination, recommended since 2007 for girls and since 2021 for all young people aged 11 to 14 (with catch-up vaccination possible up to age 26), remains insufficiently followed. Today, only 40.7% of adolescents are vaccinated in France, and the Auvergne Rhône Alpes region remains below the targets (47.5% for girls and 12.3% for boys). This is still far from the national target of 80% vaccination coverage by 2030, while 6,400 new cases of HPV-related cancers are reported each year. The PIMCOP regional study aims to assess the impact of a primary prevention intervention, co-developed with stakeholders and implemented in middle and high schools, on the HPV vaccination rate at 6 months among 11-17 year olds.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHPV animationThis presentation will enable young people to gather key information about HPV: - What is it? - How is it transmitted? - Who is affected? - What are the possible consequences? - How can you protect yourself? To this end, it was decided to hold a 1.5-hour presentation for 9th grade classes in middle school and 12th grade classes in high school. This presentation consists of a discussion with the students about the five key pieces of information mentioned above, followed by a game to find the locations of possible cancers linked to HPV infection. Materials have been created to help facilitate this presentation, including five posters with the key messages to convey to students and the silhouette game (consisting of different cancer location markers).

Timeline

Start date
2025-12-16
Primary completion
2027-06-30
Completion
2027-06-30
First posted
2026-02-17
Last updated
2026-02-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07414719. Inclusion in this directory is not an endorsement.